Michael Roden
Michael Roden is an expert in Endocrinology at German Diabetes Center (Germany). As of October 2026, ScienceLeadR ranks Michael Roden in the top 1% of experts worldwide for Insulin Resistance, Hyperinsulinism and Glucose Metabolism Disorders. Michael Roden has authored 1,234 publications, the most recent in 2026, and is an investigator in 50 clinical trials, 5 of them ongoing. SLR score: 4,499 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Hepatology - Gastroenterology - Cardiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
- Top Glucose Metabolism Disorders key opinion leaders — ranked #11
- Top Diabetes Mellitus key opinion leaders — ranked #11
Organizations
Career arc: 1988 - 2026
Number : 1234
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 50
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 9
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| SGLT2 inhibition in addition to lifestyle intervention and risk for complications in subtypes of patients with prediabetes a randomized placebo controlled multi center trial 2024-512179-11-00 — fasting, life style, glucose intolerance, multiple chronic conditions, prediabetic state | Phase 4 | Recruiting | 2023 |
| Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA DFS) NCT06124586 — diabetes mellitus, anemia, foot, foot ulcer, angioplasty, ulcer, arteries, diabetic foot, diabetic neuropathies, food, polyneuropathies, peripheral arterial disease, therapeutics, artificial intelligence, microbiota, diabetic retinopathy, diabetes mellitus, type 2 | N/A | Recruiting | 2024 |
| Overfeeding Induced Fat tissue Stimulation NCT06193668 — overnutrition, insulin resistance, insulin, diet, maintenance, tissues, carbohydrates, adipose tissue, white, adipose tissue, lipids | N/A | Recruiting | 2024 |
| Research Study on Whether Semaglutide Works in People With Non alcoholic Steatohepatitis (NASH) NCT04822181 — liver diseases, skin, non-alcoholic fatty liver disease, liver, alcoholics, research, fatty liver, fatty liver, alcoholic, semaglutide | Phase 3 | Active not recruiting | 2021 |
| Intermittent Fasting to Improve Insulin Secretion NCT04607096 — diabetes mellitus, cells, fasting, insulin, insulin secretion, diet, energy intake, prediabetic state, therapeutics, intermittent fasting | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map